Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lerotinib vs Chemotherapy in Advanced Esophageal Squamous Cell Carcinoma
NCT04415853Phase 3Recruiting
- Sponsor
- Sunshine Lake Pharma
- Start
- Jan 2021
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of limertinib in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Sunshine Lake Pharma. Started Jan 2021; status: recruiting.
02
Drugs
limertinib
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT04415853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04415853.